Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Urogenital Neoplasms 1 Solid Neoplasm 1 Sarcoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Health Education 1 Communication 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Adenocarcinoma of Lung 1

Interventions

Radiotherapy 11 pembrolizumab 10 Nivolumab 10 Doxorubicin 10 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Cyclophosphamide 8 Biopsy 7 X-Rays 6 Ipilimumab 6 Radiation 5 Phantoms, Imaging 5 Ifosfamide 5 talimogene laherparepvec 4 cabozantinib 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 tazemetostat 3 selpercatinib 3 pazopanib 3 liposomal doxorubicin 3 fludarabine 3 Temozolomide 3 Etoposide 3 ulixertinib 2 tislelizumab 2 tipifarnib 2 palbociclib 2 larotrectinib 2 ivosidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × Geriatric Assessment × Clear all

NCT03077178 2026-01-30

SARCOLD

Institut Bergonié

Phase NA Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡